Psoriasis Treatment Center of Central New Jersey

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Dupixent and Narrowband UVB for Atopic Dermatitis	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder	Recruiting	Phase 4	2024-03-15	NCT05285839
Taltz in Combination With Enstilar for Psoriasis	Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder	Recruiting	Phase 4	2020-05-04	NCT04372277
Duobrii in Combination With Biologics	Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder	Recruiting	Phase 4	2020-04-30	NCT04119102
ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.	Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder	Recruiting	Phase 4	2020-04-15	NCT04347473
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis	Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder	Recruiting	Phase 4	2019-02-04	NCT03827876
An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients	Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder	Recruiting	Not applicable	2019-01-30	NCT03392337

Clinical trials